Improved Survival for Stage IV Melanoma From an Unknown Primary Site

Por Lee, Chris C., Faries, Mark B., Wanek, Leslie A., Morton, Donald L.
Publicado em 2009

Predictors of Occult Nodal Metastasis in Patients with Thin Melanoma

Por Faries, Mark B., Wanek, Leslie A., Elashoff, David, Wright, Byron E., Morton, Donald L.
Publicado em 2010

Is Sentinel Lymph Node Mapping Indicated for Isolated Local and In-Transit Recurrent Melanoma?

Por Yao, Katharine A., Hsueh, Eddy C., Essner, Richard, Foshag, Leland J., Wanek, Leslie A., Morton, Donald L.
Publicado em 2003

Lymphatic Mapping and Sentinel Lymphadenectomy for Early-Stage Melanoma: Therapeutic Utility and Implications of Nodal Microanatomy and Molecular Staging for Improving the Accuracy...

Por Morton, Donald L., Hoon, Dave S. B., Cochran, Alistair J., Turner, Roderick R., Essner, Richard, Takeuchi, Hiroya, Wanek, Leslie A., Glass, Edwin, Foshag, Leland J., Hsueh, Eddy C., Bilchik, Anton J., Elashoff, David, Elashoff, Robert
Publicado em 2003

Prolonged Survival of Patients Receiving Active Immunotherapy With Canvaxin Therapeutic Polyvalent Vaccine After Complete Resection of Melanoma Metastatic to Regional Lymph Nodes

Por Morton, Donald L., Hsueh, Eddy C., Essner, Richard, Foshag, Leland J., O’Day, Steven J., Bilchik, Anton, Gupta, Rishab K., Hoon, Dave S. B., Ravindranath, Mepur, Nizze, J. Anne, Gammon, Guy, Wanek, Leslie A., Wang, He-jing, Elashoff, Robert M.
Publicado em 2002